HN user
Yeah, it seems that most people don't have active viral replication which is the only thing that Paxlovid works for (it literally jams up the "scissors" that cut the viral data for replication).
It seems to work in a small subset, but that's about it.
Yes. We'd love more React devs, and a few more marketers/sales type people would help (long shot on HN, but hey, I'm here).
Send an email to info@coviddash.org and we'll talk there!
Should be back soon. Have a ticket in with my hosting.
Absolutely. That article inspired the SlateStarCodex article https://slatestarcodex.com/2018/05/08/varieties-of-argumenta..., which in turn was one of the main inspirations for this guide.
I don't really think any of the tips and strategies in this article are helpful unless both (or all) parties go in to it with this same mindset.
You'd be surprised. If there's a scale from 0 to 100, where 100 is "devoted follower of the Beginner's Guide to Arguing Constructively", I think it's possible to have a decent constructive argument with people who are about 30-40 and up. I've certainly done so myself.
If you lead by example, many people will conform the standards of the debate to your tenor. Not all, of course, but that's when you have to know when to quit.
Which means that, for example, I believe it is simply impossible to have these kind of "constructive arguments" on, say, Twitter, for example.
That was mentioned in the guide :)
everyone argues from an emotional perspective.
Certainly you'd agree that there's a scale? It's not black and white. I will edit this part to make that more clear.
Narrator: The features were not insane.
Paul Graham's Post "How to Disagree", as well as many other resources, have progressed by debate style from "destroy the other person and claim victory" to "calmly work to find common truths and update beliefs".
I often try and guide friends to this form of debate, but found that there was no one resource that summarized the mindset, knowledge and techniques needed to get there, so I wrote one.
Alternative title: the antidote to the first 2020 Presidential Debate